Marloes de Kovel: FVIII Exposure With Severe Haemophilia A on Emicizumab Prophylaxis
Marloes de Kovel, Epidemiologist and Research Coordinator at PedNet Haemophilia Research Foundation, shared a Journal of Thrombosis and Haemostasis‘s post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Delighted to share our brief report on FVIII exposure, bleeding outcomes, and inhibitor development in PUPs and MTPs with severe haemophilia A on emicizumab prophylaxis.”
Journal of Thrombosis and Haemostasis shared a post on LinkedIn:
“FVIII exposure, bleeding outcomes, and inhibitor development in 80 PUPs and MTPs with severe hemophilia A on emicizumab prophylaxis: real-world data from the PedNet Registry
Real-world data on emicizumab in infants with severe hemophilia A remain thin beyond HAVEN 7.
Across 80 previously or minimally treated infants in the PedNet Registry, first FVIII exposure was delayed and bleeding control was good, with a mean annualized bleeding rate of 0.6.
Five developed inhibitors, and preliminary analysis suggested no drop in inhibitor development. No thrombosis occurred.”
Title: Factor VIII exposure, bleeding outcomes, and inhibitor development in 80 previously untreated patients and minimally treated patients with severe hemophilia A on emicizumab prophylaxis: real-world data from the PedNet Registry
Authors: Marloes de Kovel, Gili Kenet, Jayashree Motwani, Nadine G. Andersson, Jan Blatný, Giancarlo Castaman, Manuel Carcao, Carmen Escuriola Ettingshausen, Christoph Königs, Christoph Male, Beatrice Nolan, Martin Olivieri, Caroline Oudot, Helen Pergantou, Susanna Ranta, Ester Zapotocka, Kathelijn Fischer

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 25, 2026, 14:02Innocent Mupunga: Sri Lanka Strengthens Blood Screening Quality Through International Collaboration
-
Aug 25, 2026, 14:00Mohamed Tawengi: Balancing Bleeding and Coronary Thrombosis in STEMI With ITP
-
Aug 25, 2026, 13:55Rodrigo Assar: Modeling and Simulation to Improve Thrombosis and Hemostasis Care
-
Aug 25, 2026, 13:47Ruchi Punamia: Building Stronger Foundations in Immunohematology
-
Aug 25, 2026, 13:46Owen McCarty: How Infection Activates Coagulation Through Factor XII
-
Aug 25, 2026, 13:30Danny Hsu: AIMS 2026 to Spotlight Differential Diagnosis of Thrombotic Microangiopathy
-
Aug 25, 2026, 12:26Rahaf M. Altahan: Diagnosis and Management of Factor XIII Deficiency
-
Aug 25, 2026, 12:20Christodoulos Papadopoulos: Oral Anticoagulation Monotherapy in Chronic Coronary Syndrome
-
Aug 25, 2026, 12:17Ifeanyichukwu Ifechidere: Coagulation Knowledge in Cardiology